Apocynin, NADPH Oxidase, and Vascular Cells

HomeHypertensionVol. 51, No. 2Apocynin, NADPH Oxidase, and Vascular Cells Free AccessEditorialPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessEditorialPDF/EPUBApocynin, NADPH Oxidase, and Vascular CellsA Complex Matter Rhian M. Touyz Rhian M. TouyzRhian M. Touyz From the Kidney Research Centre, Ottawa Health Research Institute, University of Ottawa, Ottawa, Ontario, Canada. Originally published17 Dec 2007https://doi.org/10.1161/HYPERTENSIONAHA.107.103200Hypertension. 2008;51:172–174Other version(s) of this articleYou are viewing the most recent version of this article. Previous versions: December 17, 2007: Previous Version 1 Apocynin (4-hydroxy-3-methoxyacetophenone), isolated from the traditional medicinal plant Picrorhiza kurroa, is a naturally occurring methoxy-substituted catechol, experimentally used as an inhibitor of reduced nicotinamide-adenine dinucleotide phosphate (NADPH) oxidase.1 Activated neutrophil NADPH oxidase, a multisubunit complex composed of membrane-associated gp91phox (Nox2) and p22phox and cytosolic subunits, p47phox, p67phox, and p40phox, produces superoxide anion, a precursor of microbicidal reactive oxygen species (ROS), thereby playing a crucial role in host defense. Apocynin inhibits the release of superoxide anion by NADPH oxidase by blocking migration of p47phox to the membrane, critically involved in initiating assembly of the functional NADPH oxidase complex.1 The underlying chemistry of apocynin's actions has been elucidated in phagocytic cells.2 Apocynin needs to be activated (oxidized) for it to inhibit the oxidase. In the presence of H2O2 and myeloperoxidase (MPO), abundant in neutrophils, apocynin is oxidized and has as products dimer and trimer derivatives resulting in diapocynin formation, the metabolically active compound of apocynin. The reactivity of apocynin radical with thiol compounds is possibly the mechanism involved in the inhibitory effect of apocynin on the NADPH oxidase complex.2,3In the early 1990s, with the discovery that cardiovascular cells possess functionally active NADPH oxidase critically involved in ROS generation and oxidative stress in the vascular wall, many investigators extended neutrophil findings and used apocynin as a pharmacological agent to specifically inhibit the vascular cell oxidase. Convincing data from numerous in vitro studies demonstrated that, in endothelial cells, vascular smooth muscle cells, and adventitial fibroblasts, apocynin blocks NADPH oxidase activity and superoxide anion generation.4,5 In vivo studies, in which mice and rats were treated with apocynin, confirmed these cellular findings.6,7 Such experiments facilitated progress in the field of ROS and vascular biology and elucidated the importance of NADPH oxidase in oxidative stress and cardiovascular, renal, and cerebrovascular disease.The above studies were all based on the presumption that apocynin regulation in nonphagocytic cells is similar to that in phagocytic cells. However, this may not be true, as highlighted in the article by Heumueller et al8 in the current issue, where it is shown that apocynin is not an inhibitor of vascular NADPH oxidase but an important antioxidant. These provocative conclusions were based on the premise that vascular cells (and other nonphagocytic cells) do not possess MPO, and, therefore, activated apocynin is not formed. In their comprehensive experiments, using HEK 293 cells overexpressing Nox subunits, Nox1, Nox2, or Nox 4, and in endothelial and vascular smooth muscle cells, in which MPO is absent, the investigators demonstrate that apocynin does not inhibit NADPH oxidase activation or the generation of superoxide. Exposure to MPO induced apocynin dimer formation and, as predicted, inhibition of the oxidase. Despite no effect on NADPH oxidase, apocynin did reduce ROS bioavailability, probably through an antioxidant mechanism.A number of important questions arise from the study by Heumueller et al, as described below.8First, is apocynin activity MPO specific? Peroxidase-deficient cells appear to be insensitive to apocynin. However, peroxidases other than MPO might influence apocynin activity. Vejražka et al9 showed that horseradish peroxidase, like MPO, induces apocynin dimer formation, with consequent NADPH oxidase inhibitory effects. Hence it is possible that vascular cells possess peroxidases, other than MPO, which may activate apocynin. This is supported by findings in endothelial cells, where apocynin dimers were identified and found to dose-dependently inhibit NADPH oxidase activity, ROS formation, and cell proliferation.4Second, can apocynin inhibit vascular cell NADPH oxidase even if these cells do not possess MPO themselves? In vivo studies demonstrated that neutrophils secrete MPO, which can be taken up by endothelial cells, in which apocynin can then be metabolized to active dimers to inhibit vascular cell NADPH oxidase (Figure). Cytokeratin 1 has been shown recently to be the protein responsible for MPO internalization in endothelial cells.10 Such a process may explain the NADPH oxidase inhibitory effects observed in many animal studies and does not necessarily refute the use of apocynin as a specific inhibitor in this context. However, such a situation is different in cultured cells, which are not exposed to leukocytes. What is difficult to explain in in vitro studies is the consistent data derived from many investigators, using different vascular cell preparations and various cells types exposed to many stimuli, which consistently show that apocynin inhibits activity of NADPH oxidase, measured by various techniques, including lucigenin chemiluminescence, p47phox phosphorylation, or p47phox/p67phox translocation. Download figureDownload PowerPointFigure. Diagram demonstrates potential effects of apocynin in phagocytic cells, such as neutrophils, and nonphagocytic cells, such as vascular cells. In neutrophils, apocynin is activated (oxidized) by MPO, in the presence of H2O2, to active dimers and trimers. NADPH oxidase activation depends on p47phox/p67phox/p40phox translocation to the cell membrane where the cytosolic complex interacts with gp91phox and p22phox. Activated apocynin inhibits NADPH oxidase–driven generation of superoxide anion by blocking the migration and interaction of p47phox with gp91phox/p22phox subunits. In vascular cells, which do not contain endogenous MPO, apocynin acts as an antioxidant, thereby reducing reactive oxygen species bioavailability, without inhibiting NADPH oxidase.8 It may be possible that vascular cells possess non-MPO peroxidases that could activate apocynin to dimers and trimers9 to inhibit vascular NADPH oxidase, which is composed of Nox2 or its homologues (Nox1, Nox4, or Nox5) as the catalytic subunit. In vivo studies suggest that apocynin in vascular cells could also be activated by MPO secreted from neutroophils.10 Dashed arrows indicate possible effects; →, stimulation; ⊥, inhibition.Third, if apocynin is indeed an antioxidant, what are the mechanisms involved? Heumueller et al8 demonstrate that, although apocynin does not inhibit activation of NADPH oxidase in vascular cells, it does reduce H2O2 and hydroxyl formation. Based on these results, it is concluded that, in this context, apocynin acts as a radical scavenger. The apocynin dimer undergoes a 2-electron transfer reaction itself, implying redox potential. However, the authors do not provide explanations as to how apocynin may have antioxidant potential.To add to the complexity, some studies demonstrated that in endothelial cells apocynin is actually a pro-oxidant that increases, rather than decreases, ROS formation.9 The main product seems to be H2O2, because stimulatory effects of apocynin were abolished by superoxide dismutase and tiron. Moreover, apocynin has been shown to decrease the intracellular reduced/oxidized glutathione ratio in stimulated monocytes, further suggesting a pro-oxidant action. Hence, apocynin seems to have opposite actions: whereas it is inhibitory in phagocytic cells, it may be stimulatory in nonphagocytic cells in certain conditions.The findings of Heumueller et al8 are thought provoking because they challenge the now-accepted dogma that vascular NADPH oxidase is a major source of vascular ROS and oxidative stress. However, it should be stressed that these conclusions were based on data derived not only from apocynin-based studies but from myriad investigations in which NADPH oxidase was probed by various strategies, including transgenic and knockout mice and gene-targeted, molecular, and pharmacological approaches, and, therefore, do not minimize the importance of vascular NADPH oxidase in the vasculature. Nevertheless, the new findings under discussion8 alert us to the fact that apocynin effects on redox status in vascular cells may not be NADPH oxidase specific and that actions of this methoxy-substituted catechol could vary depending on the cell type studied and whether MPO (or other peroxidases) is functionally present. Future studies using apocynin as an inhibitor of NADPH oxidase in nonphagocytic cells should be conducted with caution and with the knowledge that, in the absence of peroxidases and H2O2, effects on redox status may be through NADPH oxidase-independent processes, such as through radical scavenging.The opinions expressed in this editorial are not necessarily those of the editors or of the American Heart Association.Sources of FundingStudies from this laboratory were supported by grants 57786 and 44018 from the Canadian Institutes of Health Research and from the Heart and Stroke Foundation of Canada. R.M.T. is supported through a Canada Research Chair/Canadian Foundation for Innovation award.DisclosuresNone.FootnotesCorrespondence to Rhian M. Touyz, Kidney Research Centre, University of Ottawa/Ottawa Health Research Institute, 451 Smyth Rd, Ottawa, Ontario, KIH 8M5 Canada. E-mail [email protected] References 1 Stolk J, Hiltermann TJ, Dijkman JH, Verhoeven AJ. Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol. Am J Respir Cell Mol Biol. 1994; 11: 95–102.CrossrefMedlineGoogle Scholar2 Ximenes VF, Kanegae MP, Rissato SR, Galhiane MS. The oxidation of apocynin catalyzed by myeloperoxidase: proposal for NADPH oxidase inhibition. Arch Biochem Biophys. 2007; 457: 134–141.CrossrefMedlineGoogle Scholar3 Wang Q, Smith RE, Luchtefeld R, Sun AY, Simonyi A, Luo R, Sun GY. Bioavailabity of apocynin through its conversion to glycoconjugate but not to diapocynin. Phytomedicine. In press.Google Scholar4 Johnson DK, Schillinger KJ, Kwait DM, Hughes CV, McNamara EJ, Ishmael F, O'Donnell RW, Chang MM, Hogg MG, Dordick JS, Santhanam L, Ziegler LM, Holland JA. Inhibition of NADPH oxidase activation in endothelial cells by ortho-methoxy-substituted catechols. Endothelium. 2002; 9: 191–203.CrossrefMedlineGoogle Scholar5 Touyz RM, Chen X, Tabet F, Yao G, He G, Quinn MT, Pagano PJ, Schiffrin EL. Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II. Circ Res. 2002; 90: 1205–1213.LinkGoogle Scholar6 Virdis A, Neves MF, Amiri F, Touyz RM, Schiffrin EL. Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice. J Hypertens. 2004; 22: 535–542.CrossrefMedlineGoogle Scholar7 Kahles T, Luedike P, Endres M, Galla HJ, Steinmetz H, Busse R, Neumann-Haefelin T, Brandes RP. NADPH oxidase plays a central role in blood-brain barrier damage in experimental stroke. Stroke. 2007; 38: 3000–3006.LinkGoogle Scholar8 Heumüller S, Wind S, Barbosa-Sicard E, Schmidt HHHW, Busse R, Schröder K, Brandes RP. Apocynin is not an inhibitor of vascular NADPH oxidases but a potent antioxidant. Hypertension. 2008; 51: 211–217.LinkGoogle Scholar9 Vejražka M, Míček R, Štípek S. Apocynin inhibits NADPH oxidase in phagocytes but stimulates ROS production in non-phagocytic cells. Biochim Biophys Acta. 2005; 1722: 143–147.CrossrefMedlineGoogle Scholar10 Astern JM, Pendergraft WF 3rd, Falk RJ, Jennette JC, Schmaier AH, Mahdi F, Preston GA. Myeloperoxidase interacts with endothelial cell-surface cytokeratin 1 and modulates bradykinin production by the plasma kallikrein-kinin system. Am J Pathol. 2007; 171: 349–360.CrossrefMedlineGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetailsCited By Boshtam M, Kouhpayeh S, Amini F, Azizi Y, Najaflu M, Shariati L and Khanahmad H (2021) Anti-inflammatory effects of apocynin: a narrative review of the evidence, All Life, 10.1080/26895293.2021.1990136, 14:1, (997-1010), Online publication date: 1-Jan-2021. Fang J, Sheng R and Qin Z (2021) NADPH Oxidases in the Central Nervous System: Regional and Cellular Localization and the Possible Link to Brain Diseases, Antioxidants & Redox Signaling, 10.1089/ars.2021.0040, 35:12, (951-973), Online publication date: 20-Oct-2021. Chia T, Murugaiyah V, Sattar M, Khan N, Ahmad A, Abdulla M, Johns E, Mei H, Akhtar S and Ahmad F (2020) The restorative effect of apocynin and catalase in l-arginine induced hypotension on normotensive subjects – the role of oxidative stress, Physiological Research, 10.33549//physiolres.934426, (1051-1066), Online publication date: 22-Dec-2020. Mohamed R, Cao Y, Afroz R, Xu S, Ta H, Barras M, Zheng W, Little P and Kamato D (2020) ROS directly activates transforming growth factor β type 1 receptor signalling in human vascular smooth muscle cells, Biochimica et Biophysica Acta (BBA) - General Subjects, 10.1016/j.bbagen.2019.129463, 1864:1, (129463), Online publication date: 1-Jan-2020. Al-Saleh F, Khashab F, Fadel F, Al-Kandari N and Al-Maghrebi M (2020) Inhibition of NADPH oxidase alleviates germ cell apoptosis and ER stress during testicular ischemia reperfusion injury, Saudi Journal of Biological Sciences, 10.1016/j.sjbs.2020.04.024, 27:8, (2174-2184), Online publication date: 1-Aug-2020. Liu F, Lin C, Hong J, Cai C, Zhang W, Zhang J and Guo L (2019) Apocynin protects retina cells from ultraviolet radiation damage via inducing sirtuin 1, Journal of Drug Targeting, 10.1080/1061186X.2019.1663527, 28:3, (330-338), Online publication date: 15-Mar-2020. Bandyopadhaya A, Tzika A, Rahme L, Gilmore M, Kardami E and Zaborina O (2019) Pseudomonas aeruginosa Quorum Sensing Molecule Alters Skeletal Muscle Protein Homeostasis by Perturbing the Antioxidant Defense System, mBio, 10.1128/mBio.02211-19, 10:5, Online publication date: 29-Oct-2019. Lian D, Yuan H, Yin X, Wu Y, He R, Huang Y and Chen Y (2019) Puerarin inhibits hyperglycemia-induced inter-endothelial junction through suppressing endothelial Nlrp3 inflammasome activation via ROS-dependent oxidative pathway, Phytomedicine, 10.1016/j.phymed.2018.10.013, 55, (310-319), Online publication date: 1-Mar-2019. Liu Q, Liu Y, Guan X, Wu J, He Z, Kang J, Tao Z and Deng Y (2019) Effect of M2 Macrophages on Injury and Apoptosis of Renal Tubular Epithelial Cells Induced by Calcium Oxalate Crystals, Kidney and Blood Pressure Research, 10.1159/000501558, 44:4, (777-791), . Xin R, Sun X, Wang Z, Yuan W, Jiang W, Wang L, Xiang Y, Zhang H, Li X, Hou Y, Sun W and Du P (2018) Apocynin inhibited NLRP3/XIAP signalling to alleviate renal fibrotic injury in rat diabetic nephropathy, Biomedicine & Pharmacotherapy, 10.1016/j.biopha.2018.07.036, 106, (1325-1331), Online publication date: 1-Oct-2018. Kim J, Park J, Lee J and Yenari M (2017) NOX Inhibitors - A Promising Avenue for Ischemic Stroke, Experimental Neurobiology, 10.5607/en.2017.26.4.195, 26:4, (195-205), Online publication date: 31-Aug-2017. Xu C, Wang X, Gu C, Zhang H, Zhang R, Dong X, Liu C, Hu X, Ji X, Huang S and Chen L (2017) Celastrol ameliorates Cd-induced neuronal apoptosis by targeting NOX2-derived ROS-dependent PP5-JNK signaling pathway, Journal of Neurochemistry, 10.1111/jnc.13966, 141:1, (48-62), Online publication date: 1-Apr-2017. Perassa L, Graton M, Potje S, Troiano J, Lima M, Vale G, Pereira A, Nakamune A, Sumida D, Tirapelli C, Bendhack L and Antoniali C (2016) Apocynin reduces blood pressure and restores the proper function of vascular endothelium in SHR, Vascular Pharmacology, 10.1016/j.vph.2016.06.005, 87, (38-48), Online publication date: 1-Dec-2016. Virdis A, Gesi M and Taddei S (2016) Impact of apocynin on vascular disease in hypertension, Vascular Pharmacology, 10.1016/j.vph.2016.08.006, 87, (1-5), Online publication date: 1-Dec-2016. Troiano J, Potje S, Graton M, Cavalari P, Pereira A, Vale G, Nakamune A, Sumida D, Tirapelli C and Antoniali C (2016) Decreased reactive oxygen species production and NOX1, NOX2, NOX4 expressions contribute to hyporeactivity to phenylephrine in aortas of pregnant SHR, Life Sciences, 10.1016/j.lfs.2015.12.011, 144, (178-184), Online publication date: 1-Jan-2016. Seo J, Hasan M, Rahaman K, Kang M, Jung B and Kwon O (2016) A leading role for NADPH oxidase in an in-vitro study of experimental autoimmune encephalomyelitis, Molecular Immunology, 10.1016/j.molimm.2016.02.009, 72, (19-27), Online publication date: 1-Apr-2016. Rosa C, Gimenes R, Campos D, Guirado G, Gimenes C, Fernandes A, Cicogna A, Queiroz R, Falcão-Pires I, Miranda-Silva D, Rodrigues P, Laurindo F, Fernandes D, Correa C, Okoshi M and Okoshi K (2016) Apocynin influence on oxidative stress and cardiac remodeling of spontaneously hypertensive rats with diabetes mellitus, Cardiovascular Diabetology, 10.1186/s12933-016-0442-1, 15:1, Online publication date: 1-Dec-2016. Koulis C, Watson A, Gray S and Jandeleit-Dahm K (2015) Linking RAGE and Nox in diabetic micro- and macrovascular complications, Diabetes & Metabolism, 10.1016/j.diabet.2015.01.006, 41:4, (272-281), Online publication date: 1-Sep-2015. Kim J, Kim N and Yenari M (2014) Mechanisms and Potential Therapeutic Applications of Microglial Activation after Brain Injury, CNS Neuroscience & Therapeutics, 10.1111/cns.12360, 21:4, (309-319), Online publication date: 1-Apr-2015. Panday A, Sahoo M, Osorio D and Batra S (2014) NADPH oxidases: an overview from structure to innate immunity-associated pathologies, Cellular & Molecular Immunology, 10.1038/cmi.2014.89, 12:1, (5-23), Online publication date: 1-Jan-2015. Troyanova N, Shevchenko M, Boyko A, Mirzoev P, Pertseva M, Kovalenko E and Sapozhnikov A (2015) Modulating effect of extracellular HSP70 on generation of reactive oxigen species in populations of phagocytes, Russian Journal of Bioorganic Chemistry, 10.1134/S1068162015030097, 41:3, (271-279), Online publication date: 1-May-2015. Chandasana H, Chhonker Y, Bala V, Prasad Y, Sharma V and Bhatta R (2014) A rapid and sensitive LC-MS/MS analysis of diapocynin in rat plasma to investigate in vitro and in vivo pharmacokinetics, Analytical Methods, 10.1039/C4AY00697F, 6:17, (7075) Gray S, Jha J, Di Marco E and Jandeleit-Dahm K (2014) NAD(P)H oxidase isoforms as therapeutic targets for diabetic complications, Expert Review of Endocrinology & Metabolism, 10.1586/17446651.2014.887984, 9:2, (111-122), Online publication date: 1-Mar-2014. González-Peña D, Angulo J, Vallejo S, Colina-Coca C, de Ancos B, Sánchez-Ferrer C, C and C (2014) with and NADPH oxidase activity in from & Metabolism, Online publication date: J, X, J, Zhang Z and (2014) NADPH production during American Journal of and Online publication date: S, Y and K (2014) of the and activity of NADPH oxidase after injury, Free Research, Online publication date: S and Li J (2014) stress, redox signalling and endothelial in a role of NADPH oxidase Journal of Pharmacology, Online publication date: D and W (2014) in 1 Role of in . J, Seo E, Kim H, Park S, H, Kim J, D, Kim J, Zhang Y and Kim S of by inhibition of in smooth American Journal of Online publication date: A, M, P and J Role of reactive oxygen species and in the of rat Online publication date: Du J, L, A and Li J of oxidative stress in the function of and endothelium in of Journal of Pharmacology, Online publication date: B, L, M, J, J and Bendhack L modulates in renal hypertensive rat Journal of Pharmacology, Online publication date: D, Liu B, A, S, Park M, C, H and M inhibition of oxidases activation of in cells, American Journal of Online publication date: C, Y, S, Zhang Y, Lee M, Xu A, H and P and the of to and the in the with Online publication date: D, Li Y, D and The effect of on Role of NADPH oxidase and Online publication date: C and K Redox Chemistry, and for Online publication date: K, Johnson D and Ishmael F Anti-inflammatory effects of compounds on human cells, Journal of Online publication date: R, C, M, C, J, K and F superoxide production in human Life Sciences, Online publication date: K, K, P, S, J, C and Schmidt H The in NADPH oxidase Experimental & Stroke Online publication date: X, B, Kim J and Yenari M NADPH oxidase in and cerebrovascular Research, Online publication date: J and A In of & Online publication date: P, J, M and D of and of the in Journal of Blood & Metabolism, Online publication date: Y, C, Huang L and Y Apocynin oxidative stress and in spontaneously hypertensive rats of pathway, Free Research, Online publication date: S, S, K, L, S, F, J and R Apocynin and in of the American Journal of Cellular and Molecular Online publication date: D, A, N, He Y, A and Touyz R by via to and Vascular Online publication date: S, Lin J, K, J, J, A and R receptor NADPH oxidase activity in cultured human cells, Online publication date: S, P, D, S, A and Chen J damage is sensitive to H2O2 but of cellular ROS production in cells, and Molecular Mechanisms of Online publication date: M, M, L, D and P oxidative damage by in Online publication date: A, R, P, A, H, H and Role of reactive oxygen species in the regulation of cardiac Journal of Molecular and Cellular Online publication date: J, Khan A, P and Khan S Effect of NADPH oxidase inhibition on the of injury and in in the Online publication date: W, N, L, R, Wang S, K, F, B, S, M, Li R and of NADPH and Antioxidants & Redox Signaling, Online publication date: X, Guo X, C, M, J and oxygen species endothelial in Journal of Online publication date: H, K, M, N, H, Kim G, P and P Injury after Journal of Blood & Metabolism, Online publication date: G, L, J, C, L, C, E, J, A and F NADPH oxidase and reactive oxygen Role in Journal of Cellular Online publication date: Brandes R Vascular of NADPH Online publication date: N, M, T, M, T, M and S intracellular oxidative stress in human endothelial cells, Free Research, Online publication date: V, N, W, B, J, Y, I, N, N, A, Y, J, E, A, J, D, P, J, B, A and A by neutrophil myeloperoxidase Online publication date: S, S, Y, V, N, J, M and E production in endothelial cells is by NADPH oxidase, H O and American Journal of Cellular and Molecular Online publication date: Zhang C, Hu J, M, K, C and Li P Redox signaling via in injury of Biochimica et Biophysica Acta (BBA) - Molecular Cell Research,